Endometrioid Carcinoma of the Uterine Corpus With a Micropapillary Component: A Novel Prognostic Factor For Metastasis

Case report OA: closed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-06 ⓘ

This case report describes two uterine corpus endometrioid carcinomas with micropapillary components exhibiting inside-out growth and lymphovascular invasion, suggesting this pattern may predict aggressive potential and metastasis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-06 · read from full text ⓘ

This case report describes two patients with endometrioid carcinoma of the uterine corpus exhibiting a rare micropapillary component. Histological analysis revealed that these tumors displayed an inside-out growth pattern and confirmed lymphovascular invasion through immunohistochemical staining, despite the absence of nodal metastasis at the time of surgery. The authors propose that this micropapillary pattern represents a distinct invasive feature associated with aggressive biological potential and increased risk of metastasis in uterine cancer. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND/AIM: Micropapillary pattern is a morphologically distinctive form of carcinoma composed of small, hollow, or morula-like clusters of cancer cells surrounded by clear stromal spaces. The neoplastic cells characteristically display a reverse polarity, also known as an ''inside-out'' growth pattern, that is linked to higher frequencies of lymphovascular invasion and lymph nodal metastasis. To the best of our knowledge, it has not been previously recognized in uterine corpus. CASE REPORT: We report 2 cases of endometrioid carcinoma of the uterine corpus with a micropapillary component. In these cases, histological examination identified an endometrioid carcinoma that had invaded the myometrial layer. The carcinoma cells that constructed the micropapillary components were immunohistochemically positive for EMA. They lined the stromal facing surface of the cell membrane, confirming the inside-out growth pattern, and D2-40 immunohistochemistry confirmed lymphovascular invasion of carcinoma cells. CONCLUSION: We believe that the micropapillary pattern linked to higher frequencies of lymphovascular invasion and lymph nodal metastasis may be one of the most important invasive patterns in endometrioid carcinomas of the uterine corpus for predicting aggressive malignant potential, prognosis, and recurrence, although further, larger studies are required to evaluate its clinical significance.
Full text 5,582 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

To understand the biological essence of malignant neoplasms, researchers have studied their epidemiology, pathogenesis, histopathology, cytology, diagnostic molecular pathology, prognosis, and treatment. In histopathology, of the various invasive structural patterns seen in malignant neoplasms, the micropapillary pattern is one of the most well-known and clinically important. The micropapillary pattern was first described in breast cancer, where this peculiar tumor growth pattern was referred to as having an exfoliative appearance (1). It is a morphologically distinctive form of carcinoma composed of small, hollow, or morula-like clusters of cancer cells surrounded by clear stromal spaces. The neoplastic cells characteristically display a reverse polarity, also known as an ‘‘inside-out’’ growth pattern, whereby the apical poles of the cells face the stroma, not the luminal surface, and epithelial membrane antigen (EMA) immunostaining shows this polarity reversal (2,3). This pattern is linked to higher frequencies of lymphovascular invasion and lymph node metastasis (2,3). The micropapillary pattern has been reported in multiple organs, including the breast, urinary bladder, lung, colon, and uterine cervix (3-9). To the best of our knowledge, it has not been recognized in the uterine corpus. We report two cases of endometrioid carcinoma of the uterine corpus with a micropapillary component. Case Report Histological examination of the affected area identified an endometrioid carcinoma that had invaded the myometrial layer. This tumor displayed glandular architecture composed of columnar cells with pseudostratified large and markedly hyperchromatic nuclei (Figure 1B). The carcinoma cells in the invasive area formed micropapillary components (Figure 1D). The endometrioid carcinoma cells were immunohisto-chemically positive for estrogen receptor (ER) (Figure 1C). Meanwhile, the micropapillary component cells that lined the stromal facing surface of the cell membranes were immunohistochemically positive for EMA confirming the inside-out growth pattern (Figure 1E). These cells were immunonegative for ER. We confirmed lymphovascular invasion of carcinoma cells by D2-40 immunostaining (Figure 1F). Pathological examination indicated that she did not have nodal metastasis (pelvic lymph node with para-aortic lymph node) at the time of surgery. Gross examination showed an exophytic mass (70×55 mm) of the uterine corpus ( The endometrioid carcinoma cells were immunohisto-chemically positive for ER (Figure 2C). Meanwhile, micropapillary component cells were immunohisto-chemically positive for EMA, as in Case 1 (Figure 2E), and focal and weakly positive for ER. The lymphovascular invasion of carcinoma cells was confirmed by D2-40 immunostaining (Figure 2F). Pathological examination indicated that she did not have nodal metastasis (pelvic lymph node) at the time of surgery. The Research Ethics Committee of the Faculty of Medicine, University of Yamanashi approved this case report (approval number: 2665).

Discussion

We reported two cases of endometrioid carcinoma of the uterine corpus with the micropapillary component. The myoinvasive cases of endometrioid endometrial adenocarcinoma were classified on the basis of the 5 patterns of invasion: infiltrating glands, microcystic elongated and fragmented (MELF), broad front, adenomyosis like, and adenoma malignum (10). Gland infiltration was associated with higher stage, lymphovascular invasion, and recurrence (10). MELF pattern consisted of characteristic glands with a microcystic appearance or elongated structure and a compressed, sometimes slit-like lumen (11). The cancer cells lining these glands had conspicuous eosinophilic cytoplasm, squamoid appearance, or flattened and endothelial cell-like appearance (11). The presence of MELF pattern was associated with lymphovascular invasion and lymph node metastasis (11). The uterus is divided into corpus and cervix. Stewart et al. reported eight cases of uterine cervical carcinomas with micropapillary component (9). The micropapillary component of the primary uterine cervical carcinomas was usually focal and sometimes initially overlooked. The metastatic carcinomas in the four patients with recurrence or disseminated disease all showed a pure micropapillary pattern. The authors indicated that micropapillary elements in uterine cervical carcinomas have aggressive malignant potential, similar to micropapillary carcinomas in general. Meanwhile, both of our cases had lymphovascular invasion confirmed by D2-40 immunostaining which indicates that the micropapillary component in the uterine corpus may be associated with lymphovascular invasion and lymph node metastasis. Although we believe that the micropapillary pattern is most likely a sixth important invasive pattern in endometrioid carcinoma of the uterine corpus following the 5 patterns listed above, further, larger studies are needed to evaluate its clinical significance. Conflicts of Interest The Authors declare no competing interests regarding this study. Authors’ Contributions KM collected and analyzed the data and drafted the manuscript. KO, KT, HF and TK analyzed the data and contributed to the final draft of the manuscript. All Authors read and approved the final manuscript.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:40:24.586789+00:00
unpaywall
last seen: 2026-10-28T06:33:34.531809+00:00